Skip to main content
. 2008 Apr 21;26(26):3268–3276. doi: 10.1016/j.vaccine.2008.04.001

Table 2.

Percentage of NS1-expressing cells also expressing SIV Gag following infection with SIV gag VLP vaccines

SIVgag construct % gag positive
WT 69.3 ± 0.08
DX 22.5 ± 0.49
OPT 40.2 ± 0.43
gag-pol 87.0 ± 0.01

Each VLP vaccine was titred on Vero cells and cultured for 48 h. IFA was then performed using anti-NS1 and anti-SIV Gag (55-2F12) monoclonal antibodies and the IU titre calculated for each antibody. The ratio of the titres is represented as a percentage (Gag titre/NS1 titre × 100).